insights_auto
Why is AXGN up 2,61%?
Dive Deeperchevron_right
AXGN:NASDAQ
AxoGen, Inc Common Stock
50,02 USD
arrow_upward
+2,61%(+1,27) 1D
50,00 USD
arrow_downward
-0,04% (-0,020)bedtimeAfter hours
Closed: 6-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
48,55 USD
High
50,29 USD
Low
48,14 USD
Mkt. cap
2,99 млд
Avg. vol.
1,79 млн
Volume
1,67 млн
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
Open
48,55 USD
High
50,29 USD
Low
48,14 USD
Mkt. cap
2,99 млд
Avg. vol.
1,79 млн
Volume
1,67 млн
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
News stories
From web sources and news partners
Exchange Rates UK
·
38 мүнөт мурун
S&P 500 Slide Exposes Large Stock Moves Hidden Beneath The Index
Bloomberg.com
·
1 күн мурун
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Yahoo Finance
·
2 саат мурун
Boeing (BA): A Top 10 Dow Stock for 2027 With a Record $745B of Orders
Investor's Business Daily
·
34 мүнөт мурун
Futures Loom For Battered, Volatile Market; What To Do Now
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersАлачуа, Флорида, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com